Literature DB >> 8246754

A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas disease.

C Britto1, M A Cardoso, P Wincker, C M Morel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8246754     DOI： 10.1590/s0074-02761993000100030

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN： 0074-0276            Impact factor:   2.743


× No keyword cloud information.
  33 in total

1.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.

Authors:  Milagros Corrales; Rubén Cardozo; María Asunción Segura; Julio A Urbina; Miguel Angel Basombrío
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods.

Authors:  Juan David Ramírez; Felipe Guhl; Eufrosina Setsu Umezawa; Carlos A Morillo; Fernando Rosas; Jose A Marin-Neto; Silvia Restrepo
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

5.  Comparison of various sample preparation methods for PCR diagnosis of visceral leishmaniasis using peripheral blood.

Authors:  L Lachaud; E Chabbert; P Dubessay; J Reynes; J Lamothe; P Bastien
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Trypanosoma cruzi infection in Didelphis virginiana in relation to population parameters and variables associated with presence in rural community dwellings in Yucatan, Mexico.

Authors:  Julián Parada-López; Silvia F Hernández-Betancourt; Hugo A Ruiz-Piña; Francisco J Escobedo-Ortegón; Salvador Medina-Peralta; Jesús A Panti-May
Journal:  Ecohealth       Date:  2013-02-13       Impact factor: 3.184

7.  Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.

Authors:  L Murcia; B Carrilero; F Ferrer; M Roig; F Franco; M Segovia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-04       Impact factor: 3.267

8.  Detection of Trypanosoma cruzi infection in naturally infected dogs and cats using serological, parasitological and molecular methods.

Authors:  G F Enriquez; M V Cardinal; M M Orozco; A G Schijman; R E Gürtler
Journal:  Acta Trop       Date:  2013-03-13       Impact factor: 3.112

9.  Trypanosoma cruzi recombinant complement regulatory protein: a novel antigen for use in an enzyme-linked immunosorbent assay for diagnosis of Chagas' disease.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

10.  PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy.

Authors:  Lúcia M C Galvão; Egler Chiari; Andréa M Macedo; Alejandro O Luquetti; Simonne A Silva; Ana Lúcia S S Andrade
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.